for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zhejiang CONBA Pharmaceutical Co., Ltd.

600572.SS

Latest Trade

6.85CNY

Change

-0.02(-0.29%)

Volume

35,402,483

Today's Range

6.77

 - 

6.93

52 Week Range

5.62

 - 

11.28

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
6.87
Open
6.86
Volume
35,402,483
3M AVG Volume
835.53
Today's High
6.93
Today's Low
6.77
52 Week High
11.28
52 Week Low
5.62
Shares Out (MIL)
2,570.04
Market Cap (MIL)
18,057.76
Forward P/E
--
Dividend (Yield %)
2.22

Next Event

Q3 2019 Zhejiang CONBA Pharmaceutical Co Ltd Earnings Release

Latest Developments

More

Zhejiang CONBA Pharmaceutical's H1 Net Profit Down, To Buy Chinese Medicines Firm

Zhejiang CONBA To Issue Medium-Term Notes And Commercial Paper, To Transfer Stake In Biopharma

Zhejiang Conba Pharmaceutical's 9-Month Net Profit Up 26.27 Pct Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zhejiang CONBA Pharmaceutical Co., Ltd.

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills, granules, powders, injections, oral solutions, syrups, eye drops, nasal drops, ear drops, ointments and others. Its products are applied in cardiovascular and cerebrovascular diseases, urinary system diseases, digestive diseases, respiratory diseases, endocrine system, nervous system, anti-infection and other treatment areas. The Company also provides value-added services. The Company distributes its products within domestic markets.

Industry

Major Drugs

Contact Info

Binjiang Technological & Economc Prk

No.568 Bnkng Rd,

Hi-Tech Development Zone

+86.571.87774710

http://gfgs.conbagroup.com/

Executive Leadership

Jiqiang Hu

Chairman of the Board

Ruwei Wang

President, Director

Wei Liang Zhang

Vice Chairman of the Board

Zhenxian Yuan

Chief Financial Officer

Yuezhong Chen

Finance Director, Vice President

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
EPS (CNY)

2016

0.180

2018

0.301
Price To Earnings (TTM)
28.00
Price To Sales (TTM)
2.63
Price To Book (MRQ)
3.26
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
64.74
LT Debt To Equity (MRQ)
23.21
Return on Investment (TTM)
9.96
Return on Equity (TTM)
6.33

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up